In a Dynamic Susceptibility Contrast (DSC) study, gadolinium is imaged during its first pass through the vascular space. At this time the concentration of gadolinium is high (often exceeding 2-3 mM). This shortens both T2 due to dipole-dipole interactions and T2* due to susceptibility changes from gadolinium compartmentalization within the vessels. Water molecules diffusing nearby experience a changing magnetic field and undergo accelerated transverse relaxation. This translates to signal loss on T2- or T2*-weighted sequences.
|
Advanced Discussion (show/hide)»
As you might expect, the relationship between the presence of Gd in a vessel and its T2(*) effects are more complex than the simple discussion above suggests.
First, standard Gd contrast agents are confined to the plasma and do not enter red blood cells. Accordingly, there are susceptibility effects within the intravascular space itself as well as those due to intravascular-extravascular space compartmentalization. The extent of compartmentalization varies with hematocrit. Hematocrit, in turn, differs between larger blood vessels and capillaries.
Field strength is important, as susceptibility effects generally scale with Bo².
The pulse sequence used will also determine the relative contributions of susceptibility from different vessels. GRE sequences will be sensitive to T2* dephasing from all vessels, but especially the larger ones; SE sequences will be more sensitive to T2 effects in small arterioles, venules and capillaries.
Finally, the orientation of blood vessels with respect to Bo affects both intravascular and extravascular susceptibility phenomena. For example, blood vessels oriented parallel to Bo will have no extravascular susceptibility changes while those oriented perpendicularly will exhibit a maximal effect. This curious phenomenon results from the angular dependence of dipole-dipole relaxation described in a prior Q&A.
Boxerman J, Hambert L, Rosen B, Weisskoff R. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34:555-566. (explains susceptibility effect differences between large and small vessels).
Can the T2-shortening effects of gadolinium ever be observed on routine MR imaging?
What is the difference between T2 and T2*?